TY - JOUR
T1 - Same-Day Discharge after Percutaneous Left Atrial Appendage Closure
T2 - Insights from the Nationwide Readmission Database 2015-2019
AU - Zahid, Salman
AU - Hashem, Anas
AU - Rai, Devesh
AU - Khan, Muhammad Zia
AU - Ullah, Waqas
AU - Gowda, Smitha
AU - Munir, Muhammad Bilal
AU - Tan, Bryan E.Xin
AU - Velagapudi, Poonam
AU - Naidu, Srihari
AU - Goel, Sachin
AU - Bhatt, Deepak L.
AU - Depta, Jeremiah P.
N1 - Publisher Copyright:
© 2023 Elsevier Inc.
PY - 2023/5
Y1 - 2023/5
N2 - Data on the feasibility of same-day discharge (SDD) following percutaneous left atrial appendage closure (LAAC) remain limited. We analyzed the US Nationwide Readmission Database from quarter four of 2015 to 2019 to study the safety and feasibility of SDD after LAAC. After excluding non-elective cases and in-hospital deaths, a total of 54,880 cases of LAAC were performed during the study period. Following LAAC, 2% (n=1077) of patients underwent SDD, 88% (n=48,428) underwent next-day discharge (NDD), 5.2% (n=2881) were discharged on the second day (ScD), and 4.5% of patients (n = 2494) were discharged 3 or more days after LAAC. There was no difference in 30-day readmission rates between SDD and NDD (7.3% [n=79] vs 7.4% [n=3585], P=0.94). The hospitalization costs were significantly lower for SDD compared with NDD ($22,963 vs $27,079, P≤0.01). SDD discharge following percutaneous LAAC appears to be safe and is associated with lower hospitalization costs. Further prospective studies are needed to determine the safety and feasibility of SDD with percutaneous LAAC.
AB - Data on the feasibility of same-day discharge (SDD) following percutaneous left atrial appendage closure (LAAC) remain limited. We analyzed the US Nationwide Readmission Database from quarter four of 2015 to 2019 to study the safety and feasibility of SDD after LAAC. After excluding non-elective cases and in-hospital deaths, a total of 54,880 cases of LAAC were performed during the study period. Following LAAC, 2% (n=1077) of patients underwent SDD, 88% (n=48,428) underwent next-day discharge (NDD), 5.2% (n=2881) were discharged on the second day (ScD), and 4.5% of patients (n = 2494) were discharged 3 or more days after LAAC. There was no difference in 30-day readmission rates between SDD and NDD (7.3% [n=79] vs 7.4% [n=3585], P=0.94). The hospitalization costs were significantly lower for SDD compared with NDD ($22,963 vs $27,079, P≤0.01). SDD discharge following percutaneous LAAC appears to be safe and is associated with lower hospitalization costs. Further prospective studies are needed to determine the safety and feasibility of SDD with percutaneous LAAC.
UR - http://www.scopus.com/inward/record.url?scp=85148096528&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85148096528&partnerID=8YFLogxK
U2 - 10.1016/j.cpcardiol.2023.101588
DO - 10.1016/j.cpcardiol.2023.101588
M3 - Review article
C2 - 36638903
AN - SCOPUS:85148096528
VL - 48
JO - Current Problems in Cardiology
JF - Current Problems in Cardiology
SN - 0146-2806
IS - 5
M1 - 101588
ER -